Effect of modified-live bovine viral diarrhea virus type 2 vaccine on performance, health, temperature, and behavior response in high-risk beef heifer calves
Keywords:behavior, bovine respiratory disease, bovine viral diarrhea virus, temperature, vaccination
The objective of this study was to determine performance, health, vaginal temperature, and behavior differences in calves vaccinated upon feedlot arrival with a multivalent modified-live virus (MLV) vaccine which included bovine viral diarrhea virus (BVDV) type 2 antigen and calves vaccinated with a vaccine which did not include BVOV type 2. Eightythree beef heifer calves were randomly assigned to receive a multivalent MLV vaccine containing either bovine herpesvirus-1, BVDV type 1, bovine respiratory syncytial virus, and parainfluenza type-3 virus (n = 42; 4-WAY), or a MLVvaccine of similar formulation which also contained a BVDV type 2 antigen (n = 41; 5-WAY). Performance outcomes were evaluated at 30 and 60 days. Vaginal temperatures were evaluated hourly and daily. Cattle behavior activity was monitored with a real-time location system. Calves in the 5-WAY group had greater average daily gain (P = 0.026) at 60 days, excluding dead animals, compared to 4-WAY group. Treatment group was not associated with vaginal temperature. Calves in 5-WAY spent a greater (P ~ 0.01) amount of time at the feed bunk on days 0, 2, 3, and 4 compared to 4-WAY. Results of this study indicate no adverse effects from administering an additional strain of BVOV type 2 to high-risk heifers. Behavioral responses indicate a potential advantage to administer 5-WAY vaccine compared to 4-WAY vaccine.